Skip to main content

Conditioning Regimens

  • Chapter
  • First Online:
Book cover Blood and Marrow Transplant Handbook

Abstract

The preferred conditioning regimen should be capable of eliminating or reducing the tumor load from the malignant disorder, provide adequate immunosuppression to prevent graft rejection, and have manageable side effects or regimen-related toxicities. Traditionally, all allogeneic conditioning regimens were ablative, meaning that stem cell support was required in order to attain hematopoietic recovery of the bone marrow. More recently, there has been a trend in multiple patient populations to move toward reduced-intensity regimens (RIT), which are defined as any regimen that does not require stem cell support for hematopoietic recovery and results in low hematologic toxicity and mixed donor–recipient chimerism in a substantial proportion of patients in the early post-transplantation period.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Champlin, R., Khouri, I., Anderlini, P., De Lima, M., Hosing, C., McMannis, J., et al. (2003). Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation: Biology and current indications. Oncology, 17:94–100.

    PubMed  Google Scholar 

  • Chunduri, S., Dobogai, L.C., Peace, D., Saunthararajah, Y., Chen, H.Y., Mahmud, N., et al. (2006). Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant, 38:477–482.

    Article  CAS  PubMed  Google Scholar 

  • Ciurea, S.O., Anderssen, B.S. (2009). Busulfan in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 15:523–536.

    Article  CAS  PubMed  Google Scholar 

  • Giralt, S., Ballen, K., Rizzo, D., Bacigalupo, A., Horowitz, M., Pasquini, M., et al. (2009). Reduced intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant, 15:367–369.

    Article  PubMed  Google Scholar 

  • Al-Ali, H., Cross, M., Lange, T., Freund, M., Dolken, G., Niederwieser, D., et al. (2009). Low-dose total body irradiation-based regimens as preparative regimens for allogeneic haematopoietic cell transplantation in acute myelogenous leukemia. Curr Opin Oncol, 21(Suppl 1), S17–S22.

    Article  CAS  PubMed  Google Scholar 

  • Khouri, I. (2006). Reduced-intensity regimens in allogeneic stem-cell transplantation for non-Hodgkins lymphoma and chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program, 390–397

    Google Scholar 

  • Lekakis, L., de Padua Silva, L., de Lima, M. (2008). Novel preparative regimens in hematopoietic stem cell transplantation. Curr Pharm Design, 14:1923–1935.

    Article  CAS  Google Scholar 

  • Margolin, K., Synold, T., Longmate, J., Doroshow, J.H. (2001). Methodologic guidelines for the design of high dose chemotherapy regimens. Biol Blood Marrow Transplant, 7:414–432.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Bubalo, J. (2010). Conditioning Regimens. In: Maziarz, R., Slater, S. (eds) Blood and Marrow Transplant Handbook. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7506-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-7506-5_5

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-7505-8

  • Online ISBN: 978-1-4419-7506-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics